Literature DB >> 33963286

Loss of liver X receptor β in astrocytes leads to anxiety-like behaviors via regulating synaptic transmission in the medial prefrontal cortex in mice.

Xin Li1, Hongyu Zhong1, Zhongke Wang1, Rui Xiao1, Per Antonson2, Tianyao Liu1, Chuan Wu1, Jiao Zou1, Lian Wang1, Ivan Nalvarte2, Haiwei Xu3, Margaret Warner4, Jan-Ake Gustafsson5,6, Xiaotang Fan7.   

Abstract

Astrocytes are integral components of synaptic transmission, and their dysfunction leads to neuropsychiatric disorders such as anxiety and depression. Liver X receptor β (LXRβ) is expressed in astrocytes, and LXRβ global knockout mice shows impaired synaptic formation. In order to define the role of LXRβ in astrocytes, we used a conditional Cre-loxP system to specifically remove LXRβ from astrocytes. We found that this deletion caused anxiety-like but not depressive-like behaviors in adult male mice. This behavioral phenotype could be completely reproduced by selective deletion of LXRβ in astrocytes in the medial prefrontal cortex (mPFC). Pyramidal neurons in layer V of mPFC are involved in mood behaviors. We found that there was an increased spontaneous excitatory synaptic transmission in layer V pyramidal neurons of the mPFC of these mice. This was concurrent with increased dendritic complexity, despite normal appearance and number of dendritic spines. In addition, gene ontology analysis of RNA sequencing revealed that deletion of astrocytic LXRβ led to the enrichment of the process of synaptic transmission in mPFC. Finally, we also confirmed that renormalized excitatory synaptic transmission in layer V pyramidal neurons alleviated the anxiety in mice with astrocytic LXRβ deletion in mPFC. Together, our findings reveal that astrocytic LXRβ in mPFC is critical in the regulation of synaptic transmission, and this provides a potential new target for treatment of anxiety-like behavior.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33963286     DOI: 10.1038/s41380-021-01139-5

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  53 in total

Review 1.  Versatile control of synaptic circuits by astrocytes: where, when and how?

Authors:  Glenn Dallérac; Jonathan Zapata; Nathalie Rouach
Journal:  Nat Rev Neurosci       Date:  2018-12       Impact factor: 34.870

2.  Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC).

Authors:  Jonathan S Comer; Carlos Blanco; Deborah S Hasin; Shang-Min Liu; Bridget F Grant; J Blake Turner; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

3.  Detection of bacterial growth by the Malthus conductance meter.

Authors:  N C Baynes; J Comrie; J H Prain
Journal:  Med Lab Sci       Date:  1983-04

Review 4.  Targeting the modulation of neural circuitry for the treatment of anxiety disorders.

Authors:  David H Farb; Marcia H Ratner
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 6.  AUGMENTATION STRATEGIES FOR TREATMENT-RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Beth Patterson; Michael Van Ameringen
Journal:  Depress Anxiety       Date:  2016-05-12       Impact factor: 6.505

Review 7.  The pharmacologic treatment of anxiety disorders: a review of progress.

Authors:  Lakshmi N Ravindran; Murray B Stein
Journal:  J Clin Psychiatry       Date:  2010-07       Impact factor: 4.384

8.  Region-specific deletions of the glutamate transporter GLT1 differentially affect seizure activity and neurodegeneration in mice.

Authors:  Junya Sugimoto; Moeko Tanaka; Kaori Sugiyama; Yukiko Ito; Hidenori Aizawa; Miho Soma; Tomoko Shimizu; Akira Mitani; Kohichi Tanaka
Journal:  Glia       Date:  2017-12-06       Impact factor: 7.452

Review 9.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

Review 10.  Glia as architects of central nervous system formation and function.

Authors:  Nicola J Allen; David A Lyons
Journal:  Science       Date:  2018-10-12       Impact factor: 47.728

View more
  3 in total

Review 1.  Synapse-specific roles for microglia in development: New horizons in the prefrontal cortex.

Authors:  Sara V Blagburn-Blanco; Megan S Chappell; Lindsay M De Biase; Laura A DeNardo
Journal:  Front Mol Neurosci       Date:  2022-08-08       Impact factor: 6.261

2.  Microglia activation in the mPFC mediates anxiety-like behaviors caused by Staphylococcus aureus strain USA300.

Authors:  Jiao Zou; Weilong Shang; Ling Yang; Tianyao Liu; Lian Wang; Xin Li; Jinghui Zhao; Xiancai Rao; Junwei Gao; Xiaotang Fan
Journal:  Brain Behav       Date:  2022-08-17       Impact factor: 3.405

Review 3.  Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain.

Authors:  Xian-Guo Liu
Journal:  J Inflamm Res       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.